Methicillin-resistant Staphylococcus aureus (MRSA): focus on community-associated MRSA

References

• National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32(8): 470–485
   Google Scholar
• Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus-. a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 15; 36(2): 131–139
   Google Scholar
• File TM Jr. Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting. Cleve Urn J Med 2007; 74(Suppl 4): S6–S10
   Google Scholar
• Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infection in the United States. JAMA 2007; 298:1763–1771
   Google Scholar
• Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186(9): 1344–1347
   Google Scholar
• Frazee, et al. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 2005; 45:311–320
   Google Scholar
• Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Meth ici Ilin-resistant Staphylococcus aureus infections among patients in the emergency department NEJM 2006; 355: 666–674
   Google Scholar
• Arbeit RD, Maki D, Tally FP, et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004; 38:1673–1681
   Google Scholar
• Corey R. Stryjewski M, O'Riordan W, et al. Televancin for the treatment of complicated skin and skin structure infections: results of the ATLAS L Study. [abstract LB-17] Program and abstracts of the 44th Annual meeting of the Infectious Diseases Society of America. Toronto, Oct 12–15, 2006
   Google Scholar
• Diederen BM, Kluytmans JA. The emergence of infections with community-associated methicillin resistant Staphylococcus aureus. J Infect 2006 52(3): 157–168
   Google Scholar
• Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. NEJM 2005; 352: 1436–1444
   Google Scholar
• Naimi TS, LeDell KB, Boxrud DJ, et al. Community-acquired methicillin Staphylococcus aureus in Minnesota. Clin Infect Dis 2001; 33: 990–996
   Google Scholar
• File TM Jr. Community-associated methicillin resistant Staphylococcus aureus-. not only a cause of skin infections, also a new cause of pneumonia: editorial review. Cuff Opin Infect Dis 2005; 18: 123–124
   Google Scholar
• Hageman JC, Francis J, Uyeki TM, et al. Emergence of methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia during the influenza season, 2003–2004 [abstract LB-8]. Program and abstracts of the 42nd annual meeting of the Infectious Diseases Society of America. Boston, Sept 30-Oct 3, 2004
   Google Scholar
• Kollef MH, ShorrA, TabakYP, eta'. Epidemiology and outcomes of healthcare-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128(6): 3854–3862
   Google Scholar
• Ruhe JJ, Smith N, Bradsher RW, et al. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome. Clin Infect Dis 2007; 44: 777–784
   Google Scholar
• Ruhe JJ, Menon A. Tetracycline as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother2007; 51: 3298–3303
   Google Scholar
• Mandell LA, Wunderink RG, Anzueto A. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl 2): 51–S46
   Google Scholar